Gemcitabine, epirubicin and paclitaxel (GET) vs. 5-fluorouracil, epirubicin and cyclophosphamide (FEC) as first-line treatment in metastatic breast cancer: interim toxicity analysis of a randomised, multicenter phase iii trial of the Central European Cooperative Oncology Group (CECOG)

✍ Scribed by T. Brodowicz; S. Beslija; J. Cervek; Z. Mrsic-Krmpotic; I. Tchernozemsky; C. Wiltschke; N. Ghilezan; M. Grgic; J. Jassem; C. Zielinski

• Book ID: 117658564
• Publisher: Elsevier Science
• Year: 2001
• Tongue: English
• Weight: 166 KB
• Volume: 37
• Category: Article
• ISSN: 0959-8049
• DOI: 10.1016/s0959-8049(01)81201-6